Clinical Trials Directory

Trials / Completed

CompletedNCT01956396

Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in Zimbabwe

Phase I of Study of Safety and Efficacy of the PrePex Device for MC Programs in Zimbabwe

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
53 (actual)
Sponsor
Ministry of Health and Child Welfare, Zimbabwe · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The protocol, approved by the Medical Research Council, was issued to assess the safety and efficacy of the non-surgical device for applying it to the national scale up of adult male circumcision in Zimbabwe

Detailed description

Models show that to have the highest impact on the HIV epidemic, circumcision of up to 80% of men in high prevalence countries, where MC rates are low, needs to be achieved (UNAIDS 2009; Manicaland HIV/STD Prevention Project, 2008; Bollinger, et al, 2009). Hallett and colleagues in 2008 showed that for Zimbabwe specifically, HIV incidence could be reduced between 25% to 35% if about 50% of men are circumcised. All modelings conducted show that MC programs must be part of a comprehensive HIV prevention package as MC alone will not tip the HIV epidemic into a terminal decline. The PrePex Device offers hope for rapid scale up of adult male circumcision in resource limited settings. Once the safety and efficacy have been established, it is important to conduct operations research to determine how best to implement both device and surgical circumcisions in the national program. Thus, the Zimbabwe MOHCW is planning a three phase trial in order to determine the safety of the PrePexTM device, its performance and the ease of use in an implementation roll out.

Conditions

Interventions

TypeNameDescription
DEVICEPrePex™ devicePrePex™ device for adult male circumcision. The non-surgical PrePex™ device with No Injected Anesthesia

Timeline

Start date
2011-10-01
Primary completion
2011-11-01
Completion
2011-11-01
First posted
2013-10-08
Last updated
2013-10-08

Locations

1 site across 1 country: Zimbabwe

Source: ClinicalTrials.gov record NCT01956396. Inclusion in this directory is not an endorsement.